-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DRgj1GRBBcGTD4Pun9ql29BJ9cu8PrEe1Dm4UN0ge8cDxWt/7yYbOvTXAlc8XLbs gJwoFe4O+GNieJg/UtyX3A== 0000922423-99-000267.txt : 19990217 0000922423-99-000267.hdr.sgml : 19990217 ACCESSION NUMBER: 0000922423-99-000267 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCELL CORP /DE/ CENTRAL INDEX KEY: 0000811641 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010382980 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-39373 FILM NUMBER: 99541837 BUSINESS ADDRESS: STREET 1: 56 EVERGREEN DR CITY: PORTLAND STATE: ME ZIP: 04103 BUSINESS PHONE: 2078782770 MAIL ADDRESS: STREET 1: 56 EVERGREEN DRIVE CITY: PORTLAND STATE: ME ZIP: 04103 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ARIES FINANCIAL SERVICES INC CENTRAL INDEX KEY: 0001007000 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128324379 SC 13G/A 1 SCHEDULE 13G AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------------------------------- SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 ----------------------------------------- Immucell, Corp. ----------------------------------------- (Name of Issuer) Common Stock, par value $0.1 per share ------------------------------------------ (Title of Class of Securities) 452525306 ------------- (CUSIP Number) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes to Schedule 13G). 1 SCHEDULE 13G CUSIP No. 452525306 Page 2 of 9 - -------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Paramount Capital Asset Management, Inc. - -------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3) SEC USE ONLY - -------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5) SOLE VOTING POWER 0 NUMBER ---------------------------------------------------------- OF 6) SHARED VOTING POWER SHARES 0 BENEFICIALLY ---------------------------------------------------------- OWNED BY 7) SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------- PERSON 8) SHARED DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0 - -------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- 2 SCHEDULE 13G CUSIP No. 452525306 Page 3 of 9 - -------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Aries Master Fund, a Cayman Islands exempted company - -------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3) SEC USE ONLY - -------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands - -------------------------------------------------------------------------------- 5) SOLE VOTING POWER 0 NUMBER ---------------------------------------------------------- OF 6) SHARED VOTING POWER SHARES 0 BENEFICIALLY ---------------------------------------------------------- OWNED BY 7) SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------- PERSON 8) SHARED DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0 - -------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON OO - -------------------------------------------------------------------------------- 3 SCHEDULE 13G CUSIP No. 452525306 Page 4 of 9 - -------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Aries Domestic Fund, L.P. - -------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3) SEC USE ONLY - -------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5) SOLE VOTING POWER 0 NUMBER ---------------------------------------------------------- OF 6) SHARED VOTING POWER SHARES 0 BENEFICIALLY ---------------------------------------------------------- OWNED BY 7) SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------- PERSON 8) SHARED DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0 - -------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON PN - -------------------------------------------------------------------------------- 4 SCHEDULE 13G CUSIP No. 452525306 Page 5 of 9 - -------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Lindsay A. Rosenwald, M.D. - -------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3) SEC USE ONLY - -------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5) SOLE VOTING POWER 0 NUMBER ---------------------------------------------------------- OF 6) SHARED VOTING POWER SHARES 0 BENEFICIALLY ---------------------------------------------------------- OWNED BY 7) SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------- PERSON 8) SHARED DISPOSITIVE POWER WITH 0 - -------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0 - -------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- 5 Item 1. (a) Name of Issuer: Immucell, Corp. (the "Company") (b) Address of Issuer's Principal Executive Offices: Immucell Corporation 56 Evergreen Drive Portland, ME 04130 Item 2. (a) Name of Person Filing: This statement is filed on behalf of Paramount Capital Asset Management, Inc. ("Paramount Capital"), Aries Domestic Fund, L.P. (The "Partnership"), The Aries Master Fund, a Cayman Island exempted company (the "Master Fund") and Lindsay A. Rosenwald, M.D. ("Dr. Rosenwald" and collectively, "Reporting Parties"). See attached Exhibit A which is a copy of their agreement in writing to file this statement on behalf of each of them. (b) Address of Principal Business Office or, if None, Residence: Paramount Capital's, the Partnership's and Dr. Rosenwald's business address is 787 Seventh Avenue, 48th Floor, New York, New York, 10019. The business address for the Master Fund is c/o MeesPierson (Cayman) Limited, P.O. Box 2003, British American Centre, Phase 3, Dr. Roy's Drive, George Town, Grand Cayman. (c) Citizenship: Dr. Rosenwald is a citizen of the United States. (d) Title of Class of Securities: Common Stock, $0.1 par value ("shares"). (e) CUSIP#: 6 452525306 Item 3. Check the box if this statement is filed pursuant to Rule 13d-1(c) [X] Item 4. Ownership: For information concerning the ownership of Common Stock of the Company by the Reporting Persons, see Items 5 through 9 and 11 of the cover pages to this schedule 13G and footnotes thereto. Item 5. Ownership of Five Percent or Less of a Class: As of the date of the filing of this Schedule 13G Amendment, the Reporting Partes ceased to be the beneficial owner of more than 5% of the shares Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported On By the Parent Holding Company: Not applicable. Item 8. Identification and Classification of Members of the Group: Not applicable. Item 9. Notice of Dissolution of Group: Not applicable. Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald, M.D. ---------------------------------- Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND, L.P. By Paramount Capital Asset Management, Inc. General Partner Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald, M.D. ---------------------------------- Lindsay A. Rosenwald, M.D. Chairman THE ARIES MASTER FUND By Paramount Capital Asset Management, Inc. Investment Manager Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald, M.D. ---------------------------------- Lindsay A. Rosenwald, M.D. Chairman Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald, M.D. ---------------------------------- Lindsay A. Rosenwald, M.D. 8 EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13G The undersigned hereby agrees to jointly prepare and file with regulatory authorities a Schedule 13G and any future amendments thereto reporting each of the undersigned's ownership of securities of Immucell, Corp., and hereby affirm that such Schedule 13G is being filed on behalf of each of the undersigned. PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald. M.D. ----------------------------------- Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND, L.P. By Paramount Capital Asset Management, Inc. General Partner Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald M.D. ----------------------------------- Lindsay A. Rosenwald, M.D. Chairman THE ARIES TRUST By Paramount Capital Asset Management, Inc. Investment Manager Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald, M.D. ----------------------------------- Lindsay A. Rosenwald, M.D. Chairman Dated: February 16, 1999 New York, NY By /s/ Lindsay A. Rosenwald, M.D. ----------------------------------- Lindsay A. Rosenwald, M.D. 9 -----END PRIVACY-ENHANCED MESSAGE-----